EUVIMEDEUVIMED entdecken
Open Access

Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma

Ahmed H Al Sharie, Mais B Tashtoush, Reem F Darweesh, Rand K Jadallah, Jawad M Al-Karaki, Samah O Al-Omari, Abdelwahab J Aleshawi, Asem A Alqudah, Amer Alemam, Hashem Abu Serhan, Ayman G Elnahry, Tamam El-Elimat und 1 weitere

Ocular Oncology and Pathology · 14.05.2026 · 1-17

DOI: 10.1159/000552459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 14.05.2026. Verfasst von Ahmed H Al Sharie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Southeast Health, Dothan, AL, USA. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Uveal melanoma (UM) is a challenging malignancy, in terms of diagnosis, risk stratification, and treatment associated with high morbidity and mortality rates. It has been demonstrated that E2F-related pathways play a significant role in the tumorigenesis and distant metastasis of UM. In this study, the E2F target-related genes were utilized to construct and validate a prognostic risk score for patients with UM.

Methods

Using the TCGA-UVM cohort (n = 80), 192 E2F target genes were screened using gene set enrichment analysis (GSEA) to identify survival-associated genes. Prognostic genes were filtered using Kaplan-Meier analysis, univariate Cox regression, and LASSO, followed by multivariate Cox regression to construct a risk score model. The model was validated using the GSE22138 cohort (n = 63). Functional annotations of the risk score and its impact on stratifying tumor immune microenvironment components were assessed.

Results

A total of 9 genes (CDC25B, NME1, RFC2, PRDX4, NASP, UBE2S, PRKDC, MCM6, and LBR) passed the model construction pipeline. The risk score categorization system showed an independent prognostic power (HR: 2.34, 95% CI: 1.11–4.90, p = 0.025) and a good predictability of the survival outcome (receiver operating characteristic curve analysis: area under the curve = 0.730, 95% CI: 0.60–0.86, p = 0.002). When analyzing the most frequently mutated gene cohorts, the risk score was significantly lower in the mutated subgroups of GNAQ, SF3B1, and EIF1AX. In contrast, the risk score was notably higher in the BAP1 mutated subgroup. Copy number analysis of chromosomal arms showed significant correlations between the risk score and 1q, 3q, 3p, 6p, 8q. The high-risk group showed significant infiltration for NK cells, plasma B cells, gamma delta T cells, follicular T cells, M1 and M2 macrophages with lower infiltration of common myeloid progenitor cells. In addition, the high-risk group showed higher immune and microenvironment scores.

Conclusion

The developed E2F target-related gene model offers a robust tool for predicting the prognosis of UM patients. As a potential risk stratification method for UM, this model could have clinical applications pending further evaluation.

Schlagwörter

Stichwörter der Autor:innen

E2F target-related genesPrognostic risk scoreThe Cancer Genome Atlas Program databaseUveal melanomaimmune microenvironment

Autor:innen und Institutionen

  • Department of Internal Medicine, Southeast Health, Dothan, AL, USA.
  • Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.
  • Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Eye Specialty Hospital, Amman, Jordan.
  • Department of Ophthalmology, Hamad Medical Corporations, Doha, Qatar.

Zitieren

APA

Al Sharie, A. H., Tashtoush, M. B., Darweesh, R. F., Jadallah, R. K., Al-Karaki, J. M., Al-Omari, S. O., Aleshawi, A. J., Alqudah, A. A., Alemam, A., Abu Serhan, H., Elnahry, A. G., El-Elimat, T., & Al-Dwairi, R. (2026). Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma. Ocular Oncology and Pathology, 1-17. https://doi.org/10.1159/000552459

Vancouver

Al Sharie AH, Tashtoush MB, Darweesh RF, Jadallah RK, Al-Karaki JM, Al-Omari SO, et al. Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma. Ocular Oncology and Pathology. 2026:1-17. doi:10.1159/000552459

BibTeX
@article{AlSharie2026,
  author = {Al Sharie, Ahmed H and Tashtoush, Mais B and Darweesh, Reem F and Jadallah, Rand K and Al-Karaki, Jawad M and Al-Omari, Samah O and Aleshawi, Abdelwahab J and Alqudah, Asem A and Alemam, Amer and Abu Serhan, Hashem and Elnahry, Ayman G and El-Elimat, Tamam and Al-Dwairi, Rami},
  title = {Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma},
  journal = {Ocular Oncology and Pathology},
  year = {2026},
  pages = {1--17},
  doi = {10.1159/000552459}
}
Kostenlos starten →